Episode 3 of our “I Am AI” docuseries introduces 12 Sigma Technologies, a San Diego-based startup that’s applying GPU-infused AI and deep learning to change that. Doctors typically use their eyes to examine CT scan images, looking for small nodules in an attempt to deduce whether they’re benign or malignant. When the nodules are small, they’re harder to spot. And the result is that lung cancer is often detected too late, leading to a dismal 17 percent survival rate, according to Xin Zhong, co-founder and CEO of 12 Sigma.
